Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management
- Language: English
- 39 Pages
- Published: August 2012
This report forecasts the Global DNA Sequencing Products market to grow at a CAGR of 18.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also been witnessing an increase in the number of DNA sequencing projects. However, the low adoption of genomic technology could pose a challenge to the growth of this market.
This report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global DNA Sequencing Products market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Agilent Technologies Inc., Hoffmann-La Roche Ltd., Illumina Inc., and Pacific Biosciences of California Inc.
The other vendors mentioned in the report are Genia Corp., International Business Machines Corp., Knome Inc., Life Technologies Corp., Oxford Nanopore Technologies Ltd., and RainDance Technologies Inc.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
01. Executive Summary
03. Market Coverage
04. Market Landscape
04.1 Market Size
04.2 Market Forecast
04.3 Five Forces Analysis
05. Geographical Segmentation
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Illumina Inc.
13.2 Agilent Technologies Inc.
13.3 F. Hoffmann-La Roche Ltd.
13.4 Pacific Biosciences of California Inc.
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global DNA Sequencing Products Market 2012-2016 (US$ billion)
Exhibit 2: Global DNA Sequencing Products Market by Geographical Segmentation 2012
Exhibit 3: Business Segmentation of Illumina Inc.
Exhibit 4: Business Segmentation of Agilent Technologies Inc.
Exhibit 5: Business Segmentation of F. Hoffmann-La Roche Ltd.
Exhibit 6: Business Segmentation of Pacific Biosciences of California Inc.
This report is based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers' understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The Global DNA Sequencing Products market has witnessed an increase in the number of acquisitions by the leading vendors recently. For instance, Illumina Inc. acquired BlueGnome Ltd. in September 2012 and Epicentre Biotechnologies Corp. in January 2011. Moreover, Agilent Technologies Inc. acquired Dako A/S in July 2012. Agilent also acquired Accelicon Technologies Inc. in February 2012. Further, Hoffmann-La Roche Ltd. acquired Verum Diagnostica GmbH in December 2011. Roche also acquired PVT Probenverteiltechnik GmbH in March 2011. The number of acquisitions is increasing and the same trend is expected to continue till 2016.''
According to the report, one of the major factors driving the Global DNA Sequencing Products market is the successful completion of the Human Genome Project (HGP). This accomplishment of the HGP has stimulated commercial improvements in the field of genomics with reference to DNA-based products.
Further, the report reveals that the low adoption of genomic technology among the biotechnology companies is expected to affect the growth of the Global DNA Sequencing Products market during the forecast period.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Agilent Technologies Inc., Hoffmann-La Roche Ltd., Illumina Inc., Pacific Biosciences of California Inc., Genia Corp., International Business Machines Corp., Knome Inc., Life Technologies Corp., Oxford Nanopore Technologies Ltd., RainDance Technologies Inc.